blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1912963

EP1912963 - CYCLIC KETAL BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.08.2012
Database last updated on 04.06.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
[N/P]
Former [2012/33]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway NJ 07065-0907 / US
Former [2012/32]For all designated states
Schering Corporation
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
Former [2010/10]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
Former [2008/17]For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
Inventor(s)01 / NANTERMET, Philippe, G.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
02 / VACCA, Joseph, P.
126 East Lincoln Avenue
Rahway, New Jersey 07065-0907 / US
 [2008/17]
Representative(s)Buchan, Gavin MacNicol
Merck Sharp & Dohme Limited
European Patent Department
Hertford Road
Hoddesdon
Hertfordshire EN11 9BU / GB
[N/P]
Former [2011/41]Buchan, Gavin MacNicol
Merck Sharp & Dohme Limited European Patent Department Hertford Road Hoddesdon
Hertfordshire EN11 9BU / GB
Former [2009/37]Buchan, Gavin MacNicol
Merck Sharp & Dohme Limited European Patent Department Hertford Road Hoddesdon
Hertfordshire EN11 9BU / GB
Former [2008/17]Buchan, Gavin MacNicol
Merck & Co., Inc. Hertford Road
Hoddesdon, Herts. EN11 9BU / GB
Application number, filing date06789003.828.07.2006
[2008/17]
WO2006US29766
Priority number, dateUS20050705075P03.08.2005         Original published format: US 705075 P
[2008/17]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007019111
Date:15.02.2007
Language:EN
[2007/07]
Type: A2 Application without search report 
No.:EP1912963
Date:23.04.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 15.02.2007 takes the place of the publication of the European patent application.
[2008/17]
Type: B1 Patent specification 
No.:EP1912963
Date:12.10.2011
Language:EN
[2011/41]
Search report(s)International search report - published on:US03.01.2008
(Supplementary) European search report - dispatched on:EP22.07.2010
ClassificationIPC:C07D307/22, A61K31/443, A61K31/341
[2008/17]
CPC:
C07D307/22 (EP,US); A61P25/28 (EP); A61P43/00 (EP);
C07D405/12 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/17]
TitleGerman:CYCLISCHE KETALE ALS BETA-SEKRETASE-INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER-KRANKHEIT[2008/17]
English:CYCLIC KETAL BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE[2008/17]
French:INHIBITEURS DE BETA-SECRETASE A CETAL CYCLIQUE DESTINES AU TRAITEMENT DE LA MALADIE D'ALZHEIMER[2008/17]
Entry into regional phase03.03.2008National basic fee paid 
03.03.2008Search fee paid 
03.07.2008Designation fee(s) paid 
03.07.2008Examination fee paid 
Examination procedure03.07.2008Examination requested  [2008/33]
03.02.2011Amendment by applicant (claims and/or description)
02.05.2011Communication of intention to grant the patent
26.08.2011Fee for grant paid
26.08.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  02.05.2011
Opposition(s)13.07.2012No opposition filed within time limit [2012/38]
Fees paidRenewal fee
27.03.2008Renewal fee patent year 03
08.07.2009Renewal fee patent year 04
08.07.2010Renewal fee patent year 05
16.07.2011Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.07.2006
AT12.10.2011
BE12.10.2011
CY12.10.2011
CZ12.10.2011
DK12.10.2011
EE12.10.2011
FI12.10.2011
IT12.10.2011
LT12.10.2011
LV12.10.2011
PL12.10.2011
RO12.10.2011
SE12.10.2011
SI12.10.2011
SK12.10.2011
TR12.10.2011
BG12.01.2012
GR13.01.2012
ES23.01.2012
IS12.02.2012
PT13.02.2012
[2014/34]
Former [2014/21]AT12.10.2011
BE12.10.2011
CY12.10.2011
CZ12.10.2011
DK12.10.2011
EE12.10.2011
FI12.10.2011
IT12.10.2011
LT12.10.2011
LV12.10.2011
PL12.10.2011
RO12.10.2011
SE12.10.2011
SI12.10.2011
SK12.10.2011
TR12.10.2011
BG12.01.2012
GR13.01.2012
ES23.01.2012
IS12.02.2012
PT13.02.2012
Former [2013/29]AT12.10.2011
BE12.10.2011
CY12.10.2011
CZ12.10.2011
DK12.10.2011
EE12.10.2011
FI12.10.2011
IT12.10.2011
LT12.10.2011
LV12.10.2011
PL12.10.2011
RO12.10.2011
SE12.10.2011
SI12.10.2011
SK12.10.2011
BG12.01.2012
GR13.01.2012
ES23.01.2012
IS12.02.2012
PT13.02.2012
Former [2013/22]AT12.10.2011
BE12.10.2011
CY12.10.2011
CZ12.10.2011
DK12.10.2011
EE12.10.2011
IT12.10.2011
LT12.10.2011
LV12.10.2011
PL12.10.2011
RO12.10.2011
SE12.10.2011
SI12.10.2011
SK12.10.2011
BG12.01.2012
GR13.01.2012
ES23.01.2012
IS12.02.2012
PT13.02.2012
Former [2013/07]AT12.10.2011
BE12.10.2011
CY12.10.2011
CZ12.10.2011
DK12.10.2011
EE12.10.2011
IT12.10.2011
LT12.10.2011
LV12.10.2011
PL12.10.2011
RO12.10.2011
SE12.10.2011
SI12.10.2011
SK12.10.2011
BG12.01.2012
GR13.01.2012
IS12.02.2012
PT13.02.2012
Former [2012/37]BE12.10.2011
CY12.10.2011
CZ12.10.2011
DK12.10.2011
EE12.10.2011
IT12.10.2011
LT12.10.2011
LV12.10.2011
PL12.10.2011
RO12.10.2011
SE12.10.2011
SI12.10.2011
SK12.10.2011
BG12.01.2012
GR13.01.2012
IS12.02.2012
PT13.02.2012
Former [2012/36]BE12.10.2011
CY12.10.2011
CZ12.10.2011
DK12.10.2011
EE12.10.2011
LT12.10.2011
LV12.10.2011
RO12.10.2011
SE12.10.2011
SI12.10.2011
SK12.10.2011
BG12.01.2012
GR13.01.2012
IS12.02.2012
PT13.02.2012
Former [2012/35]BE12.10.2011
CY12.10.2011
CZ12.10.2011
DK12.10.2011
EE12.10.2011
LT12.10.2011
LV12.10.2011
SE12.10.2011
SI12.10.2011
BG12.01.2012
GR13.01.2012
IS12.02.2012
PT13.02.2012
Former [2012/34]BE12.10.2011
CY12.10.2011
CZ12.10.2011
LT12.10.2011
LV12.10.2011
SE12.10.2011
SI12.10.2011
GR13.01.2012
IS12.02.2012
PT13.02.2012
Former [2012/28]BE12.10.2011
CY12.10.2011
LT12.10.2011
LV12.10.2011
SE12.10.2011
SI12.10.2011
GR13.01.2012
IS12.02.2012
PT13.02.2012
Former [2012/24]BE12.10.2011
LT12.10.2011
LV12.10.2011
SE12.10.2011
SI12.10.2011
GR13.01.2012
IS12.02.2012
PT13.02.2012
Former [2012/23]BE12.10.2011
LT12.10.2011
GR13.01.2012
IS12.02.2012
PT13.02.2012
Former [2012/21]BE12.10.2011
LT12.10.2011
IS12.02.2012
Former [2012/20]LT12.10.2011
Documents cited:Search[A]WO2004050609  (ELAN PHARMACEUTICAL INC [US], et al) [A] 1-12* page 173 - page 174; examples 295, 298; claim 1 *
International search[A]US2001016595  (DUCHARME YVES [CA], et al);
 [A]WO2005051914  (MERCK & CO INC [US], et al);
 [A]WO2005065195  (MERCK & CO INC [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.